Variant genotypes of MDR1 C3435T increase the risk of leukemia: evidence from 10 case–control studies

References

• Ambudkar SV, Dey S, Hrycyna CA, . Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol 1999;39:361–398.
   PubMed Web of Science ®Google Scholar
• Sakaeda T. MDR1 genotype-related pharmacokinetics: fact or fiction? Drug Metab Pharmacokinet 2005;20:391–414.
   PubMedGoogle Scholar
• Hur EH, Lee JH, Lee MJ, . C3435T polymorphism of the MDR1 gene is not associated with P-glycoprotein function of leukemic blasts and clinical outcome in patients with acute myeloid leukemia. Leuk Res 2008;32:1601–1604.
   PubMed Web of Science ®Google Scholar
• Henriquez-Hernandez LA, Murias-Rosales A, Gonzalez-Hernandez A, . Distribution of TYMS, MTHFR, p53 and MDR1 gene polymorphisms in patients with breast cancer treated with neoadjuvant chemotherapy. Cancer Epidemiol 2010;34:634–638.
   PubMed Web of Science ®Google Scholar
• Hoffmeyer S, Burk O, Richter OV, . Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA 2000;97:3473–3478.
   PubMed Web of Science ®Google Scholar
• Zubor P, Lasabova Z, Hatok J, . A polymorphism C3435T of the MDR-1 gene associated with smoking or high body mass index increases the risk of sporadic breast cancer in women. Oncol Rep 2007;18:211–217.
   PubMed Web of Science ®Google Scholar
• Cizmarikova M, Wagnerova M, Schonova L, . MDR1 (C3435T) polymorphism: relation to the risk of breast cancer and therapeutic outcome. Pharmacogenomics J 2010;10:62–69.
   PubMed Web of Science ®Google Scholar
• Henriquez-Hernandez LA, Rosales AM, Gonzalez AH, . Gene polymorphisms in TYMS, MTHFR, p53 and MDR1 as risk factors for breast cancer: a case-control study. Oncol Rep 2009;22:1425–1433.
   PubMed Web of Science ®Google Scholar
• Turgut S, Yaren A, Kursunluoglu R, . MDR1 C3435T polymorphism in patients with breast cancer. Arch Med Res 2007;38:539–544.
   PubMed Web of Science ®Google Scholar
• Khedri A, Nejat-Shokouhi A, Salek R, . Association of the colorectal cancer and MDR1 gene polymorphism in an Iranian population. Mol Biol Rep 2011;38:2939–2943.
   PubMed Web of Science ®Google Scholar
• Osswald E, Johne A, Laschinski G, . Association of MDR1 genotypes with susceptibility to colorectal cancer in older non-smokers. Eur J Clin Phamacol 2007;63:9–16.
   PubMed Web of Science ®Google Scholar
• Kurzwski M, Drozdzik M, Suchy J, . Polymorphism in the P-glycoprotein drug transporter gene in colon cancer patients. Eur J Clin Pharmacol 2005;61:389–394.
   PubMed Web of Science ®Google Scholar
• Chang H, Rha SY, Jeung HC, . Association of the ABCB1 3435C>T polymorphism and treatment outcomes in advanced gastric cancer patients treated with paclitaxel-based chemotherapy. Oncol Rep 2010;23:271–278.
   PubMed Web of Science ®Google Scholar
• Tahara T, Arisawa T, Shibata T, . Multi-drug resistance 1 polymorphism is associated with reduced risk of gastric cancer in the Japanese population. J Gastroenterol Hepatol 2007;22:1678–1682.
   PubMed Web of Science ®Google Scholar
• Sabahi Z, Salek R, Heravi RE, . Association of gastric cancer incidence with MDR1 gene polymorphism in an ethnic Iranian population. Indian J Cancer 2010;47:317–321.
   PubMed Web of Science ®Google Scholar
• Chen HC, Hu WX, Liu QX, . Genetic polymorphisms of metabolic enzymes CYP1A1, CYP2D6, GSTM1 and GSTT1 and leukemia susceptibility. Eur J Cancer Prev 2008;17:251–258.
   PubMed Web of Science ®Google Scholar
• Rao DN, Anuradha C, Vishnupriya S, . Association of an MDR1 gene polymorphism with acute leukemia in India. Asian Pacific J Cancer Prev 2010;11:1063–1066.
   PubMed Web of Science ®Google Scholar
• Semsei AF, Erdelyi DJ, Ungvari I, . Association of some rare haplotypes and genotype combinations in the MDR1 gene with childhood acute lymphoblastic leukaemia. Leuk Res 2008;32: 1214–1220.
   PubMed Web of Science ®Google Scholar
• Hattori H, Suminoe A, Wada M, . Regulatory polymorphism of multidrug resistance 1 (MDR1) gene are associated with the development of childhood acute lymphoblastic leukemia. Leuk Res 2007;31:1633–1640.
   PubMed Web of Science ®Google Scholar
• Urayama KY, Wiencke JK, Buffler PA, . MDR1 gene variants, indoor insecticide exposure, and the risk of childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev 2007;16:1172–1177.
   PubMed Web of Science ®Google Scholar
• Jamroziak K, Balcerczak E, Cebula B, . No influence of 3435C > T ABCB1 (MDR1) gene polymorphism on risk of adult acute myeloid leukemia and P-glycoprotein expression in blast cells. Ther Drug Monit 2006;28:707–711.
   PubMed Web of Science ®Google Scholar
• Jamroziak K, Mlynarski W, Balcerczak E, . Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia. Eur J Haematol 2004;72:314–321.
   PubMed Web of Science ®Google Scholar
• Leal-Ugarte E, Gutierrez-Angulo M, Macias-Gomez NM, . MDR1 C3435T polymorphism in Mexican children with acute lymphoblastic leukemia and in healthy individuals. Hum Biol 2008;80:449–455.
   PubMed Web of Science ®Google Scholar
• Penna G, Allegra A, Alonci A, . MDR-1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia:an impact on susceptibility and prognosis. Med Oncol 2011;28:1549–1554.
   PubMed Web of Science ®Google Scholar
• Jamroziak K, Balcerczak E, Smolewski P, . MDR1 (ABCB1) gene polymorphism C3435T is associated with P-glycoprotein activity in B-cell chronic lymphocytic leukemia. Pharmacol Rep 2006;58: 720–728.
   PubMed Web of Science ®Google Scholar
• Green H, Falk IJ, Lotfi K, . Association of ABCB1 polymorphisms with survival and in vitro cytotoxicty in de novo acute myeloid leukemia with normal karyotype. Pharmacogenomics J 2010 Oct 12. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med 1997;127:820–826.
   PubMed Web of Science ®Google Scholar
• Petitti DB. Meta-analysis, decision analysis, and cost-effectiveness analysis. New York: Oxford University Press; 1994.
   Google Scholar
• Egger M, Davey SG, Schneider M, . Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629–634.
   PubMed Web of Science ®Google Scholar
• Niu W, Qi Y. An updated meta-analysis of endothelial nitric oxide synthase gene: three well-characterized polymorphisms with hypertension. PLoS ONE 6(9): e24266.
   PubMed Web of Science ®Google Scholar
• Ueda K, Cardarelli C, Gottesman MM, . Expression of a full-length cDNA for the human “MDR1” gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc Natl Acad Sci USA 1987;84:3004–3008.
   PubMed Web of Science ®Google Scholar
• Tanigawara Y. Role of P-glycoprotein in drug disposition. Ther Drug Monit 2000;22:137–140.
   PubMed Web of Science ®Google Scholar
• Terao T, Hisanaga E, Sai Y, . Active secretion of drugs from the small intestinal epithelium in rats by P-glycoprotein functioning as an absorption barrier. J Pharm Pharmacol 1996;48:1083–1089.
   PubMed Web of Science ®Google Scholar
• Thiebaut F, Tsuruo T, Hamada H, . Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 1987;84:7735–7738.
   PubMed Web of Science ®Google Scholar
• Chaudhary PM, Roninson IB. Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 1991;66:85–94.
   PubMed Web of Science ®Google Scholar
• Elliott JI, Raguz S, Higgins CF. Multidrug transporter activity in lymphocytes. Br J Pharmacol 2004;143:899–907.
   PubMed Web of Science ®Google Scholar
• Hitzl M, Drescher S, Van Der Kuip H, . The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56 + natural killer cells. Pharmacogenetics 2001;11:293–298.
   PubMedGoogle Scholar
• Chong AS, Markham PN, Gebel HM, . Diverse multidrug-resistance-modification agents inhibit cytolytic activity of natural killer cells. Cancer Immunol Immunother 1993;36:133–139.
   PubMed Web of Science ®Google Scholar
• Gupta S, Kim CH, Tsuruo T, . Preferential expression and activity of multidrug resistance gene 1 product (P-glycoprotein), a functionally active efflux pump, in human CD8 + T cells:a role in cytotoxic effector function. J Clin Immunol 1992;12:451–458.
   PubMed Web of Science ®Google Scholar
• Drach J, Gsur A, Hamilton G, . Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytes. Blood 1996;88:1747–1754.
   PubMed Web of Science ®Google Scholar
• Pawlik A, Baskiewicz-Masiuk M, Machalinski B, . Involvement of C3435T and G2677T multidrug resistance gene polymorphism in release of cytokines from peripheral blood mononuclear cells treated with methotrexate and dexamethasone. Eur J Pharmacol 2005;528: 27–36.
   PubMed Web of Science ®Google Scholar
• Song P, Lamba JK, Zhang L, . G2677T and C3435T genotype and haplotype are associated with hepatic ABCB1 (MDR1) expression. J Clin Pharmacol 2006;46:373–379.
   PubMed Web of Science ®Google Scholar
• Kimchi-Sarfaty C, Oh JM, Kim IW, . A “silent” polymorphism in the MDR1 gene changes substrate specificity. Science 2007;315: 525–528.
   PubMed Web of Science ®Google Scholar
• Brinkmann U, Roots L, Eichelbaum M. Pharmacogenetics of the human drug-transporter gene MDR1: impact of polymorphisms on pharmacotherapy. Drug Discov Today 2001;6:835–839.
   PubMed Web of Science ®Google Scholar
• Nauck M, Stein U, Karger SV, . Rapid detection of the C3435T polymorphism of multidrug resistance gene 1 using fluorogenic hybridization probes. Clin Chem 2000;46:1995–1997.
   PubMed Web of Science ®Google Scholar
• Kim RB, Leake BF, Choo EF, . Identification of functionally variant MDR1 allele among European Americans and African Americans. Clin Pharmacol Ther 2001;70:189–199.
   PubMed Web of Science ®Google Scholar
• Wang D, Johnson AD, Papp AC, . Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C > T affects mRNA stability. Pharmacogenet Genomics 2005;15:693–704.
   PubMed Web of Science ®Google Scholar
• Shen LX, Basilion JP, Stanton VP Jr. Single-nucleotide polymorphisms can cause different structural folds of mRNA. Proc Natl Acad Sci USA 1999;96:7871–7876.
   PubMed Web of Science ®Google Scholar